Joseph M. Limber - 21 May 2025 Form 4 Insider Report for XOMA Royalty Corp (XOMA)

Reporting relationship: Director
Issuer ticker: XOMA
Reported as of: 21 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 May 2025, 16:47:58 UTC
Prior SEC filing: 07 Apr 2025
Next SEC filing: 31 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Thomas Burns, Attorney-in-Fact for Joseph M Limber

Key filing fact

Joseph M. Limber filed Form 4 for XOMA Royalty Corp (XOMA) on 23 May 2025.

Key facts

This page summarizes Joseph M. Limber's Form 4 filing for XOMA Royalty Corp (XOMA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 23 May 2025, 16:47.

Change

Previous filing in this sequence was filed on 07 Apr 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001216023 Primary reporting owner

LIMBER JOSEPH M

Relationship: Director
Address: C/O XOMA ROYALTY CORPORATION, 2200 POWELL STREET, SUITE 310, EMERYVILLE
Signature: /s/ Thomas Burns, Attorney-in-Fact for Joseph M Limber
Signature date: 23 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

XOMA transaction Derivative

Non-Qualified Share Option (right to buy)

Award

Transaction value: $0
Shares: +9,936
Change %
Price: $0.000000
Shares after: 9,936
Date: 21 May 2025
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 9,936
Exercise price: $25.12
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares subject to this option shall vest and become exercisable in equal monthly installments over the 12-month period following the date of grant (May 21, 2025), provided that the final installment will occur on the earlier of (i) the date of the next annual meeting of the Company's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the reporting person's continued service to the Company through each vesting date.